Portfoliotracker

Valerio Therapeutics Société anonyme

ALVIO.PA · PARIS · Healthcare Biotechnology 0/100 E

0,406 €
▼ −0,014 (−3,45 %)
Closed delayed by 15 min
Price as of 17. 11. 17:29, fetched 17. 11. 17:49
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score0 / 100 Market cap115 mil. € P/E– Forward P/E-3,6 P/S20,7 P/B– EV/EBITDA– Dividend yield– FCF yield-2,08 % EPS-0,03 € Net margin-127,1 % Return on equity– Beta2,14 Debt / equity–
52-week range 0,10 to 0,98
3-month average volume0,7 M

Finance

Where the revenue goes

Loading the income statement flow…

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

Valerio Therapeutics Société anonyme, a clinical-stage biotechnology company, develops technology platforms dedicated to the targeted delivery of therapies. The company develops PlatON, a proprietary chemical platform for DNA decoy therapies, which generates new compounds and broadens its product portfolio; DecoyTAC, a mechanism of action of DNA decoy therapies coupled with targeted protein degradation; and V-body platform, a bispecific T-cell engagers, antibody– drug conjugates, and chimeric antigen receptors. The company was formerly known as Onxeo SA and changed its name to Valerio Therapeutics Société anonyme in June 2023. Valerio Therapeutics Société anonyme was incorporated in 1997 and is headquartered in Paris, France.

Employees
41
Country
France
Data since
8. 12. 2005

Explore further

Similar companies ADOC.PATNG.PA

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account